Custom cancer vaccine fights to keep esophageal cancer at bay
NCT ID NCT05307835
Summary
This early-stage study is testing a personalized vaccine designed to train the immune system to attack a patient's specific esophageal cancer. It is for people who have already completed standard treatments including surgery, chemotherapy, and immunotherapy, with the goal of preventing the cancer from coming back. Researchers will check if the vaccine is safe and if it triggers an immune response that could help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.